|
1
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Huntly BJ and Gilliland DG: Leukaemia stem
cells and the evolution of cancer-stem-cell research. Nat Rev
Cancer. 5:311–321. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Marx J: Cancer research. Mutant stem cells
may seed cancer. Science. 301:1308–1310. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
et al: Prospective identification of tumorigenic breast cancer
cells. Proc Natl Acad Sci USA. 100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Singh SK, Hawkins C, Clarke ID, et al:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Goodell MA, Brose K, Paradis G, et al:
Isolation and functional properties of murine hematopoietic stem
cells that are replicating in vivo. J Exp Med. 183:1797–1806. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Meyers PA, Schwartz CL, Krailo M, et al:
Osteosarcoma: a randomized, prospective trial of the addition of
ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin and
high-dose methotrexate. J Clin Oncol. 23:2004–2011. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Budak-Alpdogan T, Banerjee D and Bertino
JR: Hematopoietic stem cell gene therapy with drug resistance
genes: an update. Cancer Gene Ther. 12:849–863. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dean M, Fojo T and Bates S: Tumour stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar
|
|
10
|
Donnenberg VS and Donnenberg AD: Multiple
drug resistance in cancer revisited: the cancer stem cell
hypothesis. J Clin Pharmacol. 45:872–877. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gerson SL: Drug resistance gene transfer:
Stem cell protection and therapeutic efficacy. Exp Hematol.
28:1315–1324. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Richardson C and Bank A: Preselection of
transduced murine hematopoietic stem cell populations leads to
increased long-term stability and expression of the human multiple
drug resistance gene. Blood. 86:2579–2589. 1995.PubMed/NCBI
|
|
13
|
Gibbs CP, Kukekov VG, Reith JD, et al:
Stem-like cells in bone sarcomas: implications for tumorigenesis.
Neoplasia. 7:967–976. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yin AH, Miraglia S, Zanjani ED, et al:
AC133, a novel marker for human hematopoietic stem and progenitor
cells. Blood. 90:5002–5012. 1997.PubMed/NCBI
|
|
15
|
Lee A, Kessler JD, Read TA, et al:
Isolation of neural stem cells from the postnatal cerebellum. Nat
Neurosci. 8:723–729. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sagrinati C, Netti GS, Mazzinghi B, et al:
Isolation and characterization of multipotent progenitor cells from
the Bowman’s capsule of adult human kidneys. J Am Soc Nephrol.
17:2443–2456. 2006.PubMed/NCBI
|
|
17
|
Richardson GD, Robson CN, Lang SH, et al:
CD133, a novel marker for human prostatic epithelial stem cells. J
Cell Sci. 117:3539–3545. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kordes C, Sawitza I, Müller-Marbach A, et
al: CD133+ hepatic stellate cells are progenitor cells.
Biochem Biophys Res Commun. 352:410–417. 2007.
|
|
19
|
Sugiyama T, Rodriguez RT, McLean GW and
Kim SK: Conserved markers of fetal pancreatic epithelium permit
prospective isolation of islet progenitor cells by FACS. Proc Natl
Acad Sci USA. 104:175–180. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ito Y, Hamazaki TS, Ohnuma K, et al:
Isolation of murine hair-inducing cells using the cell surface
marker prominin-1/CD133. J Invest Dermatol. 127:1052–1060. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Collins AT, Berry PA, Hyde C, et al:
Prospective identification of tumorigenic prostate cancer stem
cells. Cancer Res. 65:10946–10951. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yin S, Li J, Hu C, et al: CD133 positive
hepatocellular carcinoma cells possess high capacity for
tumorigenicity. Int J Cancer. 120:1444–1450. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hermann PC, Huber SL, Herrler T, et al:
Distinct populations of cancer stem cells determine tumor growth
and metastatic activity in human pancreatic cancer. Cell Stem Cell.
1:313–323. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Eramo A, Lotti F, Sette G, et al:
Identification and expansion of the tumorigenic lung cancer stem
cell population. Cell Death Differ. 15:504–514. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim CF, Jackson EL, Woolfenden AE, et al:
Identification of bronchioalveolar stem cells in normal lung and
lung cancer. Cell. 121:823–835. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fang D, Nguyen TK, Leishear K, et al: A
tumorigenic subpopulation with stem cell properties in melanomas.
Cancer Res. 65:9328–9337. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
et al: Identification and expansion of human colon cancer
initiating cells. Nature. 445:111–115. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Prince ME, Sivanandan R, Kaczorowski A, et
al: Identification of a subpopulation of cells with cancer stem
cell properties in head and neck squamous cell carcinoma. Proc Natl
Acad Sci USA. 104:973–978. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chambers I and Smith A: Self-renewal of
teratocarcinoma and embryonic stem cells. Oncogene. 23:7150–7160.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pan CX, Zhu W and Cheng L: Implications of
cancer stem cells in the treatment of cancer. Future Oncol.
2:723–731. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Leslie EM, Deeley RG and Cole SP:
Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2
and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol.
204:216–237. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dietrich CG, Geier A and Oude Elferink RP:
ABC of oral bioavailability: transporters as gatekeepers in the
gut. Gut. 52:1788–1795. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Staud F and Pavek P: Breast cancer
resistance protein (BCRP/ABCG2). Int J Biochem Cell Biol.
37:720–725. 2005. View Article : Google Scholar : PubMed/NCBI
|
